Examination of Efficacy and Safety of SERM or Bisphosphonates After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Who is this study for? Japanese patients with osteoporosis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The aim of this study is to examine the efficacy and adverse events in the following 3 groups in Japanese osteoporosis patients after 2-year-denosumab therapy: SERM and eldecalcitol treatment for 24 months Bisphosphonates and eldecalcitol treatment for 24 months Eldecalcitol treatment for 24 months
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 120
Healthy Volunteers: f
View:
• osteoporosis patients
Locations
Other Locations
Japan
Yukio Nakamura
RECRUITING
Matsumoto
Contact Information
Primary
Yukio Nakamura
yxn14@aol.jp
+81263372576
Time Frame
Start Date: 2018-11-24
Estimated Completion Date: 2026-11-23
Participants
Target number of participants: 90
Treatments
Active_comparator: SERM plus ELD
To examine the effects of SERM plus ELD in osteoporosis patients
Active_comparator: BP plus ELD
To examine the effects of BP plus ELD in osteoporosis patients
Active_comparator: ELD alone
To examine the effects of ELD alone in osteoporosis patients
Related Therapeutic Areas
Sponsors
Leads: Shinshu University